X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $90,525.00 -1.16%
Ethereum $3,122.19 -0.29%
BNB $888.31 -1.72%
Optimism $0.32 -1.23%
Arbitrum $0.21 +0.83%
Solana $133.24 -1.97%
Polygon $0.22 +2.77%
Cosmos $2.22 -1.17%
Avalanche $13.73 +0.35%

Bitcoin $90,525.00 -1.16%
Ethereum $3,122.19 -0.29%
BNB $888.31 -1.72%
Optimism $0.32 -1.23%
Arbitrum $0.21 +0.83%
Solana $133.24 -1.97%
Polygon $0.22 +2.77%
Cosmos $2.22 -1.17%
Avalanche $13.73 +0.35%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed